Research Overview
Gordon Chan is dedicated to understanding the cell division process and targeting errors for cancer therapy. His research focuses on mitotic checkpoint control and synthetic lethality approaches to develop new therapeutic strategies for cancer treatment.
Research Focus
Mitotic Checkpoint
Investigation of the cellular mechanisms that ensure accurate chromosome segregation during cell division and how these checkpoints can be targeted therapeutically.
Cell Cycle Kinases
Study of kinase regulation during cell division and identification of vulnerabilities that can be exploited for cancer treatment.
Mitotic Catastrophe
Understanding how cells undergo catastrophic mitotic failure and how this process can be harnessed for therapeutic benefit.
Synthetic Lethality
Development of combination treatment strategies that exploit cancer-specific vulnerabilities in cell cycle control.